WHO calls for Expressions of Interest in developing Sabin-IPV

Safe and affordable inactivated polio vaccine for low-income countries

The World Health Organization’s Global Polio Eradication Initiative (WHO/POL) is looking for Expressions of Interest from private or public sector vaccine manufacturers in developing countries interested in collaborating with WHO and Intravacc in the development, manufacture and distribution of a safe effective and affordable Sabin Inactivated Polio Vaccine (sIPV), that can be produced securely in developing country settings.

Related


Related News

   16/10/2018
Over 31 million children will be vaccinated against measles in Pakistan in a countrywide immunization campaign supported by the polio programme’s greatest asset: its people.
   28/09/2018
Head of WHO Chad Dr Jean-Bosco Ndihokubwayo speaks about the ongoing efforts to reach every child with polio vaccine across Chad
   18/09/2018
Darcy Levison, WHO Polio Eradication Officer, speaks to us about the logistical challenges of reaching every single child with polio vaccine in the Lake Chad subregion.
   12/09/2018
Anand Balachandran, former Coordinator Polio Transition, speaks to us about ensuring the infrastructure built up to eradicate polio will continue to benefit broader public health goals, long after the disease has been eradicated.
   30/08/2018
On Pakistan Independence Day, vaccinators break records for the number of children protected against polio.
   30/08/2018
By Roland Sutter, Research, Policy and Containment Team, Polio Eradication Department, WHO